What Researchers Did
Researchers investigated the effect of hyperbaric oxygen therapy (HBOT) on serum sIL-2R and fibronectin levels in 42 severe burn patients to assess its role in preventing and treating burn infections.
What They Found
In the non-HBOT group, serum sIL-2R levels significantly increased and fibronectin levels significantly decreased across all post-burn periods compared to healthy controls (P < 0.05 or P 0.05).
What This Means for Canadian Patients
Hyperbaric oxygen therapy may help stabilize immune markers and fibronectin levels in severe burn patients, potentially reducing the risk of infection. This could lead to improved outcomes and fewer complications for individuals recovering from severe burns.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's findings are based on a relatively small sample size and may not be generalizable to all burn patient populations.